Clinical Trials Browser

Phase 2 × lestaurtinib × Other hematologic neoplasm × Clear all

NCT00079482 2016-07-21

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00030186 2012-08-23

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid